Viewing Study NCT02093533


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-02-28 @ 9:25 PM
Study NCT ID: NCT02093533
Status: COMPLETED
Last Update Posted: 2018-01-17
First Post: 2014-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eculizumab in Primary MPGN
Sponsor: Mario Negri Institute for Pharmacological Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Membranoproliferative Glomerulonephritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Membranoproliferative glomerulonephritis View
None Nephrotic syndrome View
None Proteinuria View
None Alternative complement pathway View
None Complement inhibition View
None Eculizumab View